Literature DB >> 12383197

Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells.

Oliver Schulz1, Caetano Reis e Sousa.   

Abstract

In the mouse, cross-presentation is an exclusive property of the CD8alpha+ subset of dendritic cells (DC) but the basis for this selectivity remains unclear. Here we report that splenic CD8alpha+ DC are much superior to other DC subsets in internalizing dying cells in vitro. In contrast, CD8alpha+, CD8alpha- CD4+ and CD8alpha- CD4- DC subsets phagocytose bacteria or latex beads to a similar extent. Although CD8alpha+ DC are better than CD4+ DC at presenting ovalbumin (OVA)-loaded splenocytes to naïve OT-I T lymphocytes, CD4+ DC are better at presenting OVA-expressing Escherichia coli to the same T cells. In both cases, presentation is abrogated by lactacystin. These results show that both splenic CD8alpha+ and CD8alpha- DC can present exogenous antigens on major histocompatibility complex (MHC) class I via a proteasome-dependent pathway and suggest that the specialized cross-presenting function of CD8alpha+ DC is a result of their ability to endocytose dying cells rather than a unique pathway for handling endosomal contents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12383197      PMCID: PMC1782783          DOI: 10.1046/j.1365-2567.2002.01513.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

Review 1.  Cross-presentation, dendritic cells, tolerance and immunity.

Authors:  W R Heath; F R Carbone
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Dendritic cells acquire antigens from live cells for cross-presentation to CTL.

Authors:  L A Harshyne; S C Watkins; A Gambotto; S M Barratt-Boyes
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

Review 3.  Antigen presentation and T cell stimulation by dendritic cells.

Authors:  Pierre Guermonprez; Jenny Valladeau; Laurence Zitvogel; Clotilde Théry; Sebastian Amigorena
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 4.  Antigen presentation to CD8+ T cells: cross-priming in infectious diseases.

Authors:  J M den Haan; M J Bevan
Journal:  Curr Opin Immunol       Date:  2001-08       Impact factor: 7.486

5.  Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells.

Authors:  J L Pooley; W R Heath; K Shortman
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

6.  Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

Authors:  A Rodriguez; A Regnault; M Kleijmeer; P Ricciardi-Castagnoli; S Amigorena
Journal:  Nat Cell Biol       Date:  1999-10       Impact factor: 28.824

Review 7.  From evil to good: a cytolysin in vaccine development.

Authors:  G Dietrich; J Hess; I Gentschev; B Knapp; S H Kaufmann; W Goebel
Journal:  Trends Microbiol       Date:  2001-01       Impact factor: 17.079

8.  The development, maturation, and turnover rate of mouse spleen dendritic cell populations.

Authors:  A T Kamath; J Pooley; M A O'Keeffe; D Vremec; Y Zhan; A M Lew; A D'Amico; L Wu; D F Tough; K Shortman
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

9.  CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells.

Authors:  Oliver Schulz; Daniel J Pennington; Kairbaan Hodivala-Dilke; Maria Febbraio; Caetano Reis e Sousa
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

10.  CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

Authors:  J M den Haan; S M Lehar; M J Bevan
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

View more
  73 in total

Review 1.  Cross-presentation: dendritic cells and macrophages bite off more than they can chew!

Authors:  Sven Brode; Paul A Macary
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

Review 2.  From optical bench to cageside: intravital microscopy on the long road to rational vaccine design.

Authors:  Heather D Hickman; Jack R Bennink; Jonathan W Yewdell
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

3.  MyD88 expression is required for efficient cross-presentation of viral antigens from infected cells.

Authors:  Margaret Chen; Christina Barnfield; Tanja I Näslund; Marina N Fleeton; Peter Liljeström
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture.

Authors:  Petra Schnorrer; Georg M N Behrens; Nicholas S Wilson; Joanne L Pooley; Christopher M Smith; Dima El-Sukkari; Gayle Davey; Fiona Kupresanin; Ming Li; Eugene Maraskovsky; Gabrielle T Belz; Francis R Carbone; Ken Shortman; William R Heath; Jose A Villadangos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-28       Impact factor: 11.205

5.  A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells.

Authors:  John T Hunzeker; Michael D Elftman; Jennifer C Mellinger; Michael F Princiotta; Robert H Bonneau; Mary E Truckenmiller; Christopher C Norbury
Journal:  J Immunol       Date:  2010-11-22       Impact factor: 5.422

Review 6.  Antigen presentation by monocytes and monocyte-derived cells.

Authors:  Gwendalyn J Randolph; Claudia Jakubzick; Chunfeng Qu
Journal:  Curr Opin Immunol       Date:  2007-12-21       Impact factor: 7.486

Review 7.  Improving vaccines by targeting antigens to dendritic cells.

Authors:  Ken Shortman; Mireille H Lahoud; Irina Caminschi
Journal:  Exp Mol Med       Date:  2009-02-28       Impact factor: 8.718

Review 8.  Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention.

Authors:  T W H Flinsenberg; E B Compeer; J J Boelens; M Boes
Journal:  Clin Exp Immunol       Date:  2011-05-11       Impact factor: 4.330

9.  Ly6C(low) monocytes differentiate into dendritic cells and cross-tolerize T cells through PDL-1.

Authors:  YuFeng Peng; Yvette Latchman; Keith B Elkon
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.

Authors:  Lionel Franz Poulin; Mariolina Salio; Emmanuel Griessinger; Fernando Anjos-Afonso; Ligia Craciun; Ji-Li Chen; Anna M Keller; Olivier Joffre; Santiago Zelenay; Emma Nye; Alain Le Moine; Florence Faure; Vincent Donckier; David Sancho; Vincenzo Cerundolo; Dominique Bonnet; Caetano Reis e Sousa
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.